tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PTCT Stock Latest News

PTC Therapeutics price target raised to $97 from $96 at BofA
The FlyPTC Therapeutics price target raised to $97 from $96 at BofA
5d ago
PTCT
PTC Therapeutics price target raised to $75 from $63 at TD Cowen
PremiumThe Fly
PTC Therapeutics price target raised to $75 from $63 at TD Cowen
6d ago
PTCT
PTC Therapeutics assumed with Overweight from Equal Weight at Barclays
PremiumThe Fly
PTC Therapeutics assumed with Overweight from Equal Weight at Barclays
7d ago
PTCT
PTC Therapeutics: Sephience Outperformance and Votoplam De‑Risking Drive Upgraded Medium-Term Growth Outlook and Buy Rating
PremiumRatings
PTC Therapeutics: Sephience Outperformance and Votoplam De‑Risking Drive Upgraded Medium-Term Growth Outlook and Buy Rating
22d ago
PTCT
PTC Therapeutics Posts Strong 2025 Results, Updates 2026 Outlook
PremiumCompany Announcements
PTC Therapeutics Posts Strong 2025 Results, Updates 2026 Outlook
22d ago
8K
PTCT
PTC Therapeutics sees FY25 product, royalty revenue $823.4M
PremiumThe FlyPTC Therapeutics sees FY25 product, royalty revenue $823.4M
23d ago
PTCT
PTC Therapeutics sees FY26 product revenue $700M-$800M
Premium
The Fly
PTC Therapeutics sees FY26 product revenue $700M-$800M
23d ago
PTCT
PTC Therapeutics price target raised to $90 from $78 at Morgan Stanley
Premium
The Fly
PTC Therapeutics price target raised to $90 from $78 at Morgan Stanley
27d ago
PTCT
PTC Therapeutics Fully Monetizes Evrysdi Royalty Interest
PremiumCompany Announcements
PTC Therapeutics Fully Monetizes Evrysdi Royalty Interest
1M ago
8K
PTCT
PTC Therapeutics announces Japanese MHLW approval of Sephience
PremiumThe Fly
PTC Therapeutics announces Japanese MHLW approval of Sephience
1M ago
PTCT
PTC Therapeutics: Strong Growth Potential Driven by R&D Expertise and Successful Sephience Launch
PremiumRatings
PTC Therapeutics: Strong Growth Potential Driven by R&D Expertise and Successful Sephience Launch
2M ago
PTCT
Carvana initiated, Zscaler downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Carvana initiated, Zscaler downgraded: Wall Street’s top analyst calls
2M ago
ZS
CCI
Cadrenal Therapeutics appoints Lee Golden to board of directors
PremiumThe FlyCadrenal Therapeutics appoints Lee Golden to board of directors
2M ago
CVKD
PTCT
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
2M ago
PTCT
SanDisk Stock (SNDK) Jumps on S&P 500 Inclusion and Price Target Upgrades
Premium
Market News
SanDisk Stock (SNDK) Jumps on S&P 500 Inclusion and Price Target Upgrades
2M ago
IPG
OMC
Closing Bell Movers: Zoom up 4% on earnings beat
PremiumThe Fly
Closing Bell Movers: Zoom up 4% on earnings beat
2M ago
A
ZM
PTC Therapeutics to replace SanDisk in S&P 600 at open on 11/28
PremiumThe Fly
PTC Therapeutics to replace SanDisk in S&P 600 at open on 11/28
2M ago
PTCT
SNDK
Strong Market Penetration and Strategic Pricing Propel PTC Therapeutics to a Buy Rating
PremiumRatings
Strong Market Penetration and Strategic Pricing Propel PTC Therapeutics to a Buy Rating
3M ago
PTCT
PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
PremiumThe Fly
PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
3M ago
PTCT
PTC Therapeutics’ Earnings Call Highlights Success and Challenges
PremiumCompany AnnouncementsPTC Therapeutics’ Earnings Call Highlights Success and Challenges
3M ago
PTCT
PTC Therapeutics price target raised to $82 from $70 at RBC Capital
Premium
The Fly
PTC Therapeutics price target raised to $82 from $70 at RBC Capital
3M ago
PTCT
PTC Therapeutics price target raised to $63 from $50 at TD Cowen
Premium
The Fly
PTC Therapeutics price target raised to $63 from $50 at TD Cowen
3M ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >